RPRX vs. JNJ
Compare and contrast key facts about Royalty Pharma plc (RPRX) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RPRX or JNJ.
Correlation
The correlation between RPRX and JNJ is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RPRX vs. JNJ - Performance Comparison
Key characteristics
RPRX:
-0.10
JNJ:
-0.42
RPRX:
0.01
JNJ:
-0.52
RPRX:
1.00
JNJ:
0.94
RPRX:
-0.04
JNJ:
-0.36
RPRX:
-0.20
JNJ:
-0.97
RPRX:
10.98%
JNJ:
6.54%
RPRX:
21.69%
JNJ:
15.08%
RPRX:
-49.68%
JNJ:
-52.60%
RPRX:
-46.04%
JNJ:
-14.79%
Fundamentals
RPRX:
$15.03B
JNJ:
$348.19B
RPRX:
$2.54
JNJ:
$6.05
RPRX:
10.04
JNJ:
23.90
RPRX:
5.54
JNJ:
0.87
RPRX:
$1.67B
JNJ:
$66.30B
RPRX:
$1.08B
JNJ:
$45.96B
RPRX:
$1.47B
JNJ:
$22.61B
Returns By Period
In the year-to-date period, RPRX achieves a 2.08% return, which is significantly higher than JNJ's 1.11% return.
RPRX
2.08%
0.50%
3.23%
-3.97%
N/A
N/A
JNJ
1.11%
-2.06%
1.00%
-6.61%
2.94%
6.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RPRX vs. JNJ — Risk-Adjusted Performance Rank
RPRX
JNJ
RPRX vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Royalty Pharma plc (RPRX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RPRX vs. JNJ - Dividend Comparison
RPRX's dividend yield for the trailing twelve months is around 3.23%, less than JNJ's 3.36% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPRX Royalty Pharma plc | 3.23% | 3.29% | 2.85% | 1.92% | 1.71% | 0.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 3.36% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
RPRX vs. JNJ - Drawdown Comparison
The maximum RPRX drawdown since its inception was -49.68%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for RPRX and JNJ. For additional features, visit the drawdowns tool.
Volatility
RPRX vs. JNJ - Volatility Comparison
Royalty Pharma plc (RPRX) has a higher volatility of 5.79% compared to Johnson & Johnson (JNJ) at 4.40%. This indicates that RPRX's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RPRX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Royalty Pharma plc and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities